UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

De Vivo disease. GLUT-1 deficiency syndrome: a case report

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2014-03, Vol.21 (3), p.302-305

2014

Volltextzugriff (PDF)

Maladie de De Vivo ou syndrome de déficit en GLUT-1 : à propos d’un cas

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2014-03, Vol.21 (3), p.302-305

2014

Volltextzugriff (PDF)

1106 TELBIVUDINE DOES NOT CAUSE MITOCHONDRIAL TOXICITY IN HUMAN SKELETAL MUSCLE CELLS AND NEURONAL CELLS

Journal of hepatology, 2011-03, Vol.54, p.S438-S438

2011

Volltextzugriff (PDF)

Evanescent resonator chips: a universal platform with superior sensitivity for fluorescence-based microarrays

Biosensors & bioelectronics, 2003-04, Vol.18 (4), p.489-497

2003

Volltextzugriff (PDF)

Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes

Toxicology and applied pharmacology, 2003-09, Vol.191 (2), p.130-146

2003

Volltextzugriff (PDF)

Identification of human mutations in TRAF3IP1 in patients with nephronophthisis and retinal degeneration

Cilia (London), 2015-07, Vol.4 (S1), p.P52-P52, Article P52

2015

Volltextzugriff (PDF)

Evidence for the impairment of the vitamin D activation pathway by cyclosporine A

Biochemical pharmacology, 2000-02, Vol.59 (3), p.267-272

2000

Volltextzugriff (PDF)

Generation of Transducers for Fluorescence-Based Microarrays with Enhanced Sensitivity and Their Application for Gene Expression Profiling

Analytical chemistry (Washington), 2003-06, Vol.75 (11), p.2571-2577

2003

Volltextzugriff (PDF)

Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products

Toxicology and applied pharmacology, 2000-04, Vol.164 (1), p.38-45

2000

Volltextzugriff (PDF)

An Intrinsic Antibiotic Mechanism in Wounds and Tissue-Engineered Skin

Journal of investigative dermatology, 2001-03, Vol.116 (3), p.471-472

2001

Volltextzugriff (PDF)

Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles

Cell biology and toxicology, 1999-04, Vol.15 (2), p.121-135

1999

Volltextzugriff (PDF)

Functional genomics in sarcoidosis--reduced or increased apoptosis?

Swiss medical weekly, 2001-08, Vol.131 (31-32), p.459

2001

Volltextzugriff (PDF)

Report on the joint EFPIA, DIA and EMEA pharmacogenetics workshop: moving toward clinical application

Pharmacogenomics, 2004-09, Vol.5 (6), p.731-739

2004

Volltextzugriff (PDF)

Assessment of the phototoxic potential of compounds and finished topical products using a human reconstructed epidermis

In vitro & molecular toxicology, 2001, Vol.14 (3), p.157-168

2001

Volltextzugriff (PDF)

Toxicogenomics in drug development

Toxicologic pathology, 2003-09, Vol.31 (5), p.471-479

2003

Volltextzugriff (PDF)

Preclinical (epi)genomics – identifying safety biomarkers for the prediction of non-genotoxic carcinogenesis

Toxicology letters, 2013-08, Vol.221, p.S43-S43

2013

Volltextzugriff (PDF)

Non-coding RNA mechanisms and biomarkers of toxicity: from tissue to circulation

Toxicology letters, 2013-08, Vol.221, p.S47-S47

2013

Volltextzugriff (PDF)

Mineral and bone disease pattern in elderly haemodialysis patients

Nephrology, dialysis, transplantation, 2010-09, Vol.25 (9), p.3062-3070

2010

Volltextzugriff (PDF)

Pimecrolimus Identifies a Common Genomic Anti-inflammatory Profile, is Clinically Highly Effective in Psoriasis and is Well Tolerated

Journal of investigative dermatology, 2002-10, Vol.119 (4), p.876-887

2002

Volltextzugriff (PDF)

Genome-wide analysis of DNA methylation profiles in a preclinical animal model of non-genotoxic carcinogenesis

Toxicology letters, 2009-09, Vol.189, p.S135-S135

2009

Volltextzugriff (PDF)

Toxicogenomics in Drug Development

Toxicologic pathology, 2003-08, Vol.31 (5), p.471-479

2003

Volltextzugriff (PDF)

VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes

Pharmaceutical research, 2005-10, Vol.22 (10), p.1597-1613

2005

Volltextzugriff (PDF)

Functional genomics and prognosis in sarcoidosis--the critical role of antigen presentation

Sarcoidosis, vasculitis, and diffuse lung diseases, 2004-03, Vol.21 (1), p.10

2004

Volltextzugriff (PDF)

Customized cDNA chips for pharma development

Nature genetics, 1999-11, Vol.23 (S3), p.34-35

1999

Volltextzugriff (PDF)

TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis

PLoS pathogens, 2020-02, Vol.16 (2), p.e1008312-e1008312

2020

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(44)
Humans
(25)
Male
(22)
Animals
(20)
Toxicology
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(13)
Female
(12)
Gene Expression Profiling
(12)
Rats
(11)
Pharmacology & Pharmacy
(10)
Gene Expression
(9)
Adult
(8)
Middle Aged
(8)
Physical Sciences
(8)
Dermatology
(7)
Oligonucleotide Array Sequence Analysis
(6)
Pharmacology. Drug Treatments
(6)
Rats, Wistar
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

De Vivo disease. GLUT-1 deficiency syndrome: a case report

Maladie de De Vivo ou syndrome de déficit en GLUT-1 : à propos d’un cas

1106 TELBIVUDINE DOES NOT CAUSE MITOCHONDRIAL TOXICITY IN HUMAN SKELETAL MUSCLE CELLS AND NEURONAL CELLS

Evanescent resonator chips: a universal platform with superior sensitivity for fluorescence-based microarrays

Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes

Identification of human mutations in TRAF3IP1 in patients with nephronophthisis and retinal degeneration

Evidence for the impairment of the vitamin D activation pathway by cyclosporine A

Generation of Transducers for Fluorescence-Based Microarrays with Enhanced Sensitivity and Their Application for Gene Expression Profiling

Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products

An Intrinsic Antibiotic Mechanism in Wounds and Tissue-Engineered Skin

Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles

Functional genomics in sarcoidosis--reduced or increased apoptosis?

Report on the joint EFPIA, DIA and EMEA pharmacogenetics workshop: moving toward clinical application

Assessment of the phototoxic potential of compounds and finished topical products using a human reconstructed epidermis

Toxicogenomics in drug development

Preclinical (epi)genomics – identifying safety biomarkers for the prediction of non-genotoxic carcinogenesis

Non-coding RNA mechanisms and biomarkers of toxicity: from tissue to circulation

Mineral and bone disease pattern in elderly haemodialysis patients

Pimecrolimus Identifies a Common Genomic Anti-inflammatory Profile, is Clinically Highly Effective in Psoriasis and is Well Tolerated

Genome-wide analysis of DNA methylation profiles in a preclinical animal model of non-genotoxic carcinogenesis

Toxicogenomics in Drug Development

VeloceGenomics: an accelerated in vivo drug discovery approach to rapidly predict the biologic, drug-like activity of compounds, proteins, or genes

Functional genomics and prognosis in sarcoidosis--the critical role of antigen presentation

Customized cDNA chips for pharma development

TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis

Suchergebnisse filtern